Remond J A Fijneman Selected Research

Remond J A Fijneman Research Topics

Disease

42	Neoplasms (Cancer) 06/2023 - 12/2007
26	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2010
19	Adenoma (Adenomas) 11/2023 - 12/2007
16	Carcinoma (Carcinomatosis) 01/2024 - 12/2007
12	Colonic Neoplasms (Colon Cancer) 04/2022 - 09/2012
9	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2016
4	Chromosomal Instability (Chromosome Stability) 12/2022 - 04/2010
4	Inflammation (Inflammations) 01/2009 - 10/2003
3	Rectal Neoplasms (Rectal Cancer) 10/2023 - 01/2023
3	Microsatellite Instability 06/2023 - 05/2014
3	Carcinogenesis 01/2021 - 01/2009
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2020
2	Hypoxia (Hypoxemia) 01/2016 - 05/2008
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Polyps 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Ascites 01/2021
1	Adenocarcinoma 01/2019
1	Stomach Neoplasms (Stomach Cancer) 02/2014
1	Breast Neoplasms (Breast Cancer) 09/2012

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
18	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2010
14	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 02/2008
9	Messenger RNA (mRNA)IBA 10/2022 - 04/2010
5	Circulating Tumor DNAIBA 01/2023 - 12/2020
5	Calcibiotic Root Canal SealerIBA 12/2022 - 12/2007
5	Aurora Kinase AIBA 01/2018 - 04/2010
4	RNA (Ribonucleic Acid)IBA 06/2023 - 10/2017
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2019
3	ParaffinIBA 01/2021 - 06/2018
3	Formaldehyde (Formol)FDA Link 01/2021 - 06/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2003
3	Versicans (Versican)IBA 01/2017 - 09/2012
3	ProteomeIBA 03/2014 - 05/2010
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 06/2018
2	Secretory Leukocyte Peptidase InhibitorIBA 01/2022 - 10/2020
2	LipopolysaccharidesIBA 01/2021 - 05/2004
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 12/2017
2	Small Interfering RNA (siRNA)IBA 10/2017 - 01/2016
2	LumicanIBA 01/2017 - 12/2013
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 12/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 05/2004
2	ChromatinIBA 05/2014 - 05/2010
2	Interleukin-12 (IL 12)IBA 09/2012 - 05/2004
1	Phosphotransferases (Kinase)IBA 06/2023
1	TropomyosinIBA 06/2023
1	Leucovorin (Folinic Acid)FDA Link 01/2023
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 10/2022
1	Small Untranslated RNAIBA 01/2022
1	NexusIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2021
1	nidogen (entactin)IBA 01/2021
1	AerosolsIBA 01/2021
1	N 30IBA 01/2021
1	fibulin 2IBA 01/2021
1	SerpinsIBA 01/2021
1	CDX2 Transcription FactorIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	AntibodiesIBA 12/2020
1	ErbB Receptors (EGF Receptor)IBA 12/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019
1	Circular RNAIBA 01/2019
1	Complement System Proteins (Complement)IBA 12/2017
1	RNA Splicing FactorsIBA 10/2017
1	KCNQ1 Potassium ChannelIBA 12/2016
1	MLN 8237IBA 01/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Tn antigenIBA 09/2015
1	CarbohydratesIBA 09/2015
1	LigandsIBA 09/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2014
1	Carrier Proteins (Binding Protein)IBA 05/2014
1	CytokinesIBA 09/2012
1	Proteoglycans (Proteoglycan)IBA 09/2012
1	InterleukinsIBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2012
1	ChemokinesIBA 09/2012
1	Cellular Apoptosis Susceptibility ProteinIBA 08/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2012
1	Glucose Transporter Type 1IBA 06/2012
1	Prion ProteinsIBA 06/2012
1	Chitinase-3-Like Protein 1IBA 05/2012
1	OligonucleotidesIBA 02/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2012

Therapy/Procedure

9	Therapeutics 01/2023 - 09/2012
8	Adjuvant Chemotherapy 04/2022 - 12/2013
5	Neoadjuvant Therapy 01/2024 - 04/2022
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2018
2	Chemoradiotherapy 01/2024 - 01/2023
2	Hyperthermic Intraperitoneal Chemotherapy 01/2021 - 01/2019
2	Cytoreduction Surgical Procedures 01/2021 - 01/2019
1	Subcutaneous Injections 10/2022
1	Ligation 01/2018